Ken Griffin Beyond Air, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$0.36 - $0.64 $6,624 - $11,776	-18,400 Reduced 47.92%	20,000 $7,000
Q2 2024 Aug 14, 2024	BUY	$0.54 - $1.67 $7,560 - $23,380	14,000 Added 57.38%	38,400 $20,000
Q1 2024 May 15, 2024	SELL	$1.3 - $2.15 $9,620 - $15,910	-7,400 Reduced 23.27%	24,400 $42,000
Q4 2023 Feb 14, 2024	BUY	$1.4 - $2.46 $1,680 - $2,952	1,200 Added 3.92%	31,800 $62,000
Q3 2023 Nov 14, 2023	SELL	$2.31 - $4.18 $10,626 - $19,228	-4,600 Reduced 13.07%	30,600 $70,000
Q2 2023 Aug 14, 2023	SELL	$4.26 - $6.92 $35,358 - $57,436	-8,300 Reduced 19.08%	35,200 $149,000
Q1 2023 May 15, 2023	BUY	$5.65 - $7.56 $88,705 - $118,692	15,700 Added 56.47%	43,500 $293,000
Q4 2022 Feb 14, 2023	SELL	$5.47 - $7.9 $39,384 - $56,880	-7,200 Reduced 20.57%	27,800 $180,000
Q3 2022 Nov 14, 2022	SELL	$7.42 - $11.39 $628,474 - $964,733	-84,700 Reduced 70.76%	35,000 $260,000

15M

31.6K

3.4K

Ticker XAIR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,888,000
Market Cap $14.3M
Description
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.